LY2605541: all 25 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsCompletedNCT02197520Phase 1Results posted
• A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsCompletedNCT02152384Phase 1Results posted
• A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesCompletedNCT02132637Phase 3Results posted
• A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat TissueCompletedNCT02109029Phase 1Results posted
• A Study of Insulin Peglispro in Healthy Male Japanese ParticipantsCompletedNCT01995526Phase 1Results posted
• A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 DiabeticsCompletedNCT01925989Phase 1Results posted
• A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentCompletedNCT01894568Phase 3Results posted
• A Study of LY2605541 in Healthy ParticipantsCompletedNCT01877265Phase 1Results posted
• A Study of LY2605541 in Healthy Participants and in the ElderlyCompletedNCT01818245Phase 1Results posted
• A Study of LY2605541 in Participants With Type 1 Diabetes MellitusCompletedNCT01792284Phase 3Results posted
• A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 DiabetesCompletedNCT01790438Phase 3Results posted
• A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 DiabetesCompletedNCT01784211Phase 1Results posted
• A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 DiabetesCompletedNCT01771250Phase 1Results posted
• A Study of LY2605541 and Glargine in Participants With Type 1 DiabetesCompletedNCT01769404Phase 1Results posted
• A Single Dose Study of LY2605541 in Participants With Liver ImpairmentCompletedNCT01751399Phase 1Results posted
• A Study of LY2605541 Versus Insulin Glargine on Blood SugarCompletedNCT01654380Phase 1Results posted
• A Study of LY2605541 in Participants With Type 2 Diabetes MellitusCompletedNCT01582451Phase 3Results posted
• A Study in Participants With Type 1 Diabetes MellitusCompletedNCT01481779Phase 3Results posted
• A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01468987Phase 3Results posted
• A Study in Participants With Type I Diabetes MellitusCompletedNCT01454284Phase 3Results posted
• A Study in Patients With Type 2 Diabetes MellitusCompletedNCT01435616Phase 3Results posted
• A Study for Patients With Type 1 DiabetesCompletedNCT01049412Phase 2Results posted
• A Study for Patients With Type 2 DiabetesCompletedNCT01027871Phase 2Results posted
• A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes MellitusWithdrawnNCT02106364Phase 3
• A Study of LY2605541 and Insulin Lispro Mixture in Healthy ParticipantsCompletedNCT01871493Phase 1

← LY2605541 overview